Drug intelligence / Profile preview

Neuridase

Development stage
Unknown
Lead developer
Enfarma
Modality
Small Molecules
Administration
Oral
01

Overview

Neuridase is a dietary supplement and nutraceutical product primarily formulated with N-acetylneuraminic acid (sialic acid), typically in combination with B-complex vitamins such as pyridoxine (Vitamin B6) and cyanocobalamin (Vitamin B12). It is developed and marketed by Alfasigma for the support of cognitive function and neurological health. The primary active component, N-acetylneuraminic acid, is a vital structural element of gangliosides and glycoproteins found in high concentrations within the cerebral cortex and synaptic membranes. Neuridase acts by providing the necessary building blocks for the synthesis and maintenance of neural membranes, thereby facilitating effective synaptic transmission and neuroprotection. It is commonly indicated for patients experiencing cognitive fatigue, age-associated memory impairment, or recovering from neurological stressors.

Brand names
Neuridase
Other names
N-acetylneuraminic acidSialic acid
02

Targets

GD3 (Ganglioside GD3)

Beyond the preview

Go deeper on Neuridase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuridase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call